- Filed
- Aug 13, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Aug 8, 2025 | 90.27M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2025 | 85.39M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2025 | 83.91M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2024 | 70.38M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2024 | 70.12M sh |
| Capex | Q2 2025 · Jun 30, 2025 | $3.77M |
| Capex | Q2 2025 · Jun 30, 2024 | $1.53M |
| Operating Cash Flow | Q2 2025 · Jun 30, 2025 | −$31.77M |
| Operating Cash Flow | Q2 2025 · Jun 30, 2024 | −$19.96M |
| Long Term Debt | Q2 2025 · Jun 30, 2025 | $39.37M |
| Long Term Debt | Q2 2025 · Dec 31, 2024 | $28.91M |
| Short Term Investments | Q2 2025 · Jun 30, 2025 | $39.57M |
| Short Term Investments | Q2 2025 · Dec 31, 2024 | $54.19M |
| Short Term Investments restated | Q2 2025 · Jun 30, 2024 | $54.6M |
| Cash And Equivalents | Q2 2025 · Jun 30, 2025 | $26.76M |
| Cash And Equivalents | Q2 2025 · Dec 31, 2024 | $19.26M |
| Cash And Equivalents | Q2 2025 · Jun 30, 2024 | $18.6M |
| Stockholders Equity | Q2 2025 · Jun 30, 2025 | $55.63M |
| Stockholders Equity | Q2 2025 · Mar 31, 2025 | $49.63M |
| Stockholders Equity | Q2 2025 · Dec 31, 2024 | $66.93M |
| Stockholders Equity | Q2 2025 · Jun 30, 2024 | $61.45M |
| Stockholders Equity | Q2 2025 · Mar 31, 2024 | $79.27M |
| Stockholders Equity | Q2 2025 · Dec 31, 2023 | $86.62M |
| Current Liabilities | Q2 2025 · Jun 30, 2025 | $15.24M |
| Current Liabilities | Q2 2025 · Dec 31, 2024 | $23.65M |
| Total Liabilities | Q2 2025 · Jun 30, 2025 | $82.62M |
| Total Liabilities | Q2 2025 · Dec 31, 2024 | $82.08M |
| Current Assets | Q2 2025 · Jun 30, 2025 | $88.73M |
| Current Assets | Q2 2025 · Dec 31, 2024 | $98.77M |
| Total Assets | Q2 2025 · Jun 30, 2025 | $138.25M |
| Total Assets | Q2 2025 · Dec 31, 2024 | $149.01M |
| Eps Diluted | Q2 2025 · Jun 30, 2025 | −$0.16 |
| Eps Diluted | Q2 2025 · Jun 30, 2025 | −$0.40 |
| Eps Diluted | Q2 2025 · Jun 30, 2024 | −$0.32 |
| Eps Diluted | Q2 2025 · Jun 30, 2024 | −$0.49 |
| Eps Basic | Q2 2025 · Jun 30, 2025 | −$0.16 |
| Eps Basic | Q2 2025 · Jun 30, 2025 | −$0.40 |
| Eps Basic | Q2 2025 · Jun 30, 2024 | −$0.32 |
| Eps Basic | Q2 2025 · Jun 30, 2024 | −$0.49 |
| Sga Expense | Q2 2025 · Jun 30, 2025 | $12.32M |
| Sga Expense | Q2 2025 · Jun 30, 2025 | $24.67M |
| Sga Expense | Q2 2025 · Jun 30, 2024 | $15.67M |
| Sga Expense | Q2 2025 · Jun 30, 2024 | $28.53M |
| Rd Expense | Q2 2025 · Jun 30, 2025 | $13.78M |
| Rd Expense | Q2 2025 · Jun 30, 2025 | $26.72M |
| Rd Expense | Q2 2025 · Jun 30, 2024 | $11.41M |
| Rd Expense | Q2 2025 · Jun 30, 2024 | $22.66M |
| Net Income | Q2 2025 · Jun 30, 2025 | −$13.27M |
| Net Income | Q2 2025 · Jun 30, 2025 | −$33.96M |
| Net Income | Q2 2025 · Jun 30, 2024 | −$22.76M |
| Net Income | Q2 2025 · Jun 30, 2024 | −$34.26M |
| Operating Income | Q2 2025 · Jun 30, 2025 | −$12.86M |
| Operating Income | Q2 2025 · Jun 30, 2025 | −$33.35M |
| Operating Income | Q2 2025 · Jun 30, 2024 | −$22.73M |
| Operating Income | Q2 2025 · Jun 30, 2024 | −$34.62M |
| Cost Of Revenue | Q2 2025 · Jun 30, 2025 | $2.1M |
| Cost Of Revenue | Q2 2025 · Jun 30, 2025 | $4.83M |
| Cost Of Revenue | Q2 2025 · Jun 30, 2024 | $3.46M |
| Cost Of Revenue | Q2 2025 · Jun 30, 2024 | $8.32M |
| Revenue | Q2 2025 · Jun 30, 2025 | $15.33M |
| Revenue | Q2 2025 · Jun 30, 2025 | $22.87M |
| Revenue | Q2 2025 · Jun 30, 2024 | $7.98M |
| Revenue | Q2 2025 · Jun 30, 2024 | $25.05M |